TrialJCO precision oncology2023

Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.

Eric Pujade-Lauraine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.